Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Maintenance of Skeletal Integrity in Frail Elders.

Trial Profile

Maintenance of Skeletal Integrity in Frail Elders.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2015

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Acronyms ZEST
  • Most Recent Events

    • 15 May 2014 One- and two-year results presented at the 2014 Annual Scientific Meeting of the American Geriatrics Society.
    • 08 Oct 2013 Primary endpoint 'Hip-bone-mineral-density' has been met according to results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
    • 08 Oct 2013 Results presented at the 35th Annual Meeting of the American Society for Bone and Mineral Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top